Lv3
250 积分 2023-03-22 加入
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
15天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
21天前
已完结
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
23天前
已完结
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
23天前
已完结
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial
1个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
1个月前
已完结
Obinutuzumab effective for lupus nephritis
2个月前
已完结
The emergence of letermovir and maribavir drug-resistant mutations: from clinical trials to real-world studies
4个月前
已完结
Understanding antiviral intolerance in the management of cytomegalovirus; a scoping review
4个月前
已完结
Understanding antiviral intolerance in the management of cytomegalovirus; a scoping review
4个月前
已关闭
皖公网安备34019202002308
